Medexus Pharmaceuticals (MDP) to Release Earnings on Tuesday

Medexus Pharmaceuticals (TSE:MDP) is scheduled to be announcing its earnings results after the market closes on Tuesday, June 25th. Analysts expect the company to announce earnings of C($0.03) per share for the quarter.

Medexus Pharmaceuticals Price Performance

MDP traded up C$0.03 during trading on Thursday, reaching C$1.63. 200 shares of the stock traded hands, compared to its average volume of 51,190. The stock has a market cap of C$39.87 million, a price-to-earnings ratio of 4.08 and a beta of 1.82. Medexus Pharmaceuticals has a fifty-two week low of C$1.23 and a fifty-two week high of C$3.53. The stock’s 50-day simple moving average is C$1.65 and its two-hundred day simple moving average is C$1.87.

Medexus Pharmaceuticals Company Profile

Medexus Pharmaceuticals Inc operates as a specialty pharmaceutical company in Canada and the United States. The company focuses on the therapeutic areas comprising oncology, hematology, rheumatology, auto-immune diseases, allergy, and dermatology. Its primary products are IXINITY, an intravenous recombinant factor IX therapeutic for use in patients 12 years of age or older with hemophilia B; Rasuvo and Metoject, a formulation of methotrexate designed to treat rheumatoid arthritis and other auto-immune diseases; Rupall, a prescription allergy medication; and Gleolan, an optical imaging agent indicated in patients with glioma as an adjunct for the visualization of malignant tissue during surgery.